产品名称
牛IFNG /干扰素γELISA试剂盒, for serum, plasma and cell culture supernatants
species reactivity
bovine
packaging
kit of 96 wells (12 strips x 8 wells)
technique(s)
ELISA: suitable
input
sample type cell culture supernatant(s)
sample type serum
sample type plasma
assay range
inter-assay cv: <10%
intra-assay cv: <12%
sensitivity: 0.11 ng/mL
detection method
colorimetric
shipped in
wet ice
storage temp.
−20°C
Gene Information
bovine ... IFNG(281237)
Application
请参考Protocol了解详情。
General description
This ELISA antibody pair detects bovine Interferon Gamma.
Other Notes
A sample Certificate of Analysis is available for this product.
Please type the word sample in the text box provided for lot number.
Please type the word sample in the text box provided for lot number.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
存储类别
8A - Combustible corrosive hazardous materials
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Ryosuke Uchiyama et al.
Journal of immunology (Baltimore, Md. : 1950), 199(3), 1122-1130 (2017-07-05)
CD4
Vanessa A Evans et al.
AIDS (London, England), 32(11), 1491-1497 (2018-05-11)
In HIV-infected individuals on antiretroviral therapy (ART), latent HIV is enriched in CD4 T cells expressing immune checkpoint molecules, in particular programmed cell death-1 (PD-1). We therefore assessed the effect of blocking PD-1 on latency, both in vitro and in
Guanghui Zhao et al.
Acta tropica, 171, 17-23 (2017-02-28)
Aspartic proteases in the Toxoplasma gondii, called TgASP1, 2, 3, and 5, play essential roles in the life cycle. In a previous study, we have demonstrated that TgASP1 is an antigen that prolongs survival time of infected mice. As an
Marcelo Augusto Kazuo Ikeda et al.
Frontiers in microbiology, 9, 2286-2286 (2018-10-20)
Sporotrichosis is a mycosis that affects the skin, lymphatic system and other organs in humans and animals. The disease has a worldwide distribution, with endemic areas in Brazil, and is caused by a complex of species, including Sporothrix brasiliensis. Some
Krithika N Kodumudi et al.
Frontiers in immunology, 10, 1939-1939 (2019-09-03)
Patients with metastatic HER2 breast cancer (MBC) often become resistant to HER 2 targeted therapy and have recurrence of disease. The Panacea trial suggested that HER2 MBC patients were more likely to respond to checkpoint therapy if TIL were present
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持